Results 241 to 250 of about 20,692 (311)

Is Intralesional Methotrexate an Effective Alternative to Intralesional Triamcinolone in Alopecia Areata? Findings From a Randomized Controlled Trial

Journal of Cosmetic Dermatology, Volume 24, Issue 8, August 2025.
ABSTRACT Background Alopecia areata (AA) is an autoimmune condition resulting in hair loss, sometimes just in small patches but occasionally across larger areas like the entire scalp. For localized AA, treatments often involve injecting corticosteroids, such as triamcinolone acetonide (TrA), directly into the affected areas.
Narges Ghandi, Atiyeh Rashidi, Fatemeh Saberi, Robabeh Abedini, Nasim Tootoonchi, Hanie Babaie   +5 more
wiley   +1 more source

Efficacy and safety of dupilumab with concomitant topical corticosteroids in Japanese pediatric patients with moderate-to-severe atopic dermatitis: A randomized, double-blind, placebo-controlled phase 3 study

Allergology International
Background: We investigated the efficacy and safety of dupilumab in Japanese patients aged ≥6 months to
Motohiro Ebisawa, Yoko Kataoka, Akio Tanaka, Mizuho Nagao, Elizabeth Laws, Eric Mortensen, Hisakatsu Nawata, Kazuhiko Arima, Daisuke Watanabe, Xin Lu, Jennifer Maloney, Ariane Dubost-Brama, Ashish Bansal, Kenji Yahata   +13 more
doaj  

Effectiveness and safety of dupilumab in the treatment of pediatric atopic dermatitis: a real-world study from China. [PDF]

Front Immunol
Xu Y, Li B, Wang W.
europepmc   +1 more source

Safety of dupilumab in severe atopic dermatitis and infection of Covid‐19: two case reports

, 2020
Silvia Mariel Ferrucci, Maurizio Romagnuolo, Luisa Angileri, Emilio Berti, Simona Tavecchio   +4 more
openalex   +1 more source

Updated insights into the molecular pathogenesis of canine atopic dermatitis

Veterinary Dermatology, Volume 36, Issue 4, Page 375-384, August 2025.
Abstract Atopic dermatitis (AD) is a common and chronic inflammatory skin disease with frequent relapses. The genomics revolution has greatly contributed and revolutionised our knowledge of human AD; understanding the molecular skin fingerprint of AD and associated pathogenic immune pathways has led to preclinical assessments of several novel ...
Frane Banovic
wiley   +1 more source

A real-world study of dupilumab in patients with atopic dermatitis including patients with malignancy and other medical comorbiditiesCapsule Summary

JAAD International
Background: Dupilumab is a monoclonal antibody approved for the treatment of moderate-to-severe atopic dermatitis (MtS-AD). Various clinical trials have established the effectiveness and safety of dupilumab for the treatment MtS-AD; however, the real ...
Dea Metko, BSc, Maha Alkofide, MD, Mohannad Abu-Hilal, MD, MRCP   +2 more
doaj  

Aerodigestive evaluation in patients with eosinophilic asthma. [PDF]

Respir Med Case Rep
Citron C, Erkman J, Kazachkov M, Nowak-Wegrzyn A, Kesebir D.   +4 more
europepmc   +1 more source

Dupilumab treatment for prurigo nodularis: a retrospective study of 76 patients. [PDF]

Postepy Dermatol Alergol
Zhao Y, Gao C, Leng H.
europepmc   +1 more source

Dupilumab and COVID ‐19: What should we expect?

, 2020
Cataldo Patruno, Luca Stingeni, Gabriella Fabbrocini, Katharina Hansel, Maddalena Napolitano   +4 more
openalex   +1 more source

Efficacy and Safety of Biologics Targeting Type 2 Inflammation in COPD: A Systematic Review and Network Meta-Analysis. [PDF]

Int J Chron Obstruct Pulmon Dis
Li S, Yi B, Wang H, Xu X, Yu L.
europepmc   +1 more source